Immature progenitor cells can acquire characteristics of cancer stem cells thanks to the CD74-NRG1 fusion, enabling them to resist chemotherapy and targeted therapies (Laskin et al., 2020; Trombetta et al., 2021). The gene discussed is NRG1; the disease is cancer.